Whitepapers

Is your eCOA provider built to deliver clinical trial success? Our eCOA checklist provides key questions to ask when evaluating potential vendors.

Learn how to develop and market products and interventions that actually meet individuals' needs by incorporating patient input exist throughout the trial lifecycle

Determining the most effective locations and formats to get your clinical trial in front of willing, eligible participants can seem like a daunting task.. What is the most efficient way to introduce more targeted recruitment approaches?

In March 2024, the US FDA issued its guidance, “Artificial Intelligence & Medical Products: How CBER, CDER, CDRH, and OCP are Working Together,” outlining the agency’s objectives for protecting public health as artificial intelligence (AI) and other technologies become more prevalent in healthcare.

YPrime announces a new report unveiling the top challenges that clinical trial executives face when implementing eCOA, and what to look for when evaluating new solutions.

Digital biomarkers, smartphones, and wearables are transforming clinical trials by revolutionizing remote data collection and providing insights into treatment efficacy. Learn more about these exploratory endpoints and how they provide greater confidence in a clinical trial.

Explore the five key advantages that underscore the significance of digital measurements in the context of clinical trials

Learn how your team can use EHR-to-EDC technology to reduce data monitoring costs, speed up data cleaning timelines, and hit study milestones faster.

Looking for an EDC solution but overwhelmed by the process? This free guide highlights five steps to help you navigate the EDC vendor landscape and choose the right system for your study.

Inside this eBook, readers can expect to learn how to effectively navigate the various challenges associated with clinical trial data collection and reporting in the age of digitalization and at a time in which site staff are experiencing turnover and seeking more efficiency.

In this playbook, learn how a virtual site solution expands access to infectious disease clinical trials by allowing patients to enroll and participate from anywhere.

The rapid evolvement of precision oncology requires real-world data generated at a scale that unlocks insights that can not be provided from clinical trial evidence. Machine learning and large language models can be used to quickly identify information, supporting custom integrated real-world evidence solutions to make informed decisions.

Explore the pivotal role of Next-Generation Sequencing (NGS) panel customization in driving advancements in oncology research.

By employing effective use of the patient voice, companies can better boost patient engagement success.

This piece offers a practical assessment of leveraging various decentralized methodologies and technologies.

Delve into the impact of external stakeholder requirements in developing an integrated evidence generation strategy that maximizes product value.

Learn how strategic planning and patient-centric design of real-world studies drive value critical to stakeholder acceptance.

Rare disease clinical research is complex. By shifting perspective and focusing on the patient experience throughout clinical trials, trial sponsors can learn about the unique barriers faced by patients and their loved ones, improve participation rates, and optimize the impact and outcomes of such studies.

Today’s clinical studies are increasingly complex and require patient-centric trial designs, like decentralized trials, more than ever before. As trials incorporate more decentralized components there is an ever-present need for multiple system integrations to support the various trial functions, with the goal being that all trial data flows seamlessly between systems and is stored in one repository for efficient oversight and analysis. These numerous integrated systems require closely managed integration, synchronization, and supportive partnerships to minimize error and maximize efficiency. In this case study, partners endpoint and THREAD dig-in to explore how IRT can be integrated with decentralized clinical trial (DCT) technology, working through tightly integrated workflows, to provide a streamlined process, a better user experience for Sites and Participants, higher quality data and real-time access to information.

There is great value in global, multi-ethnic approaches to early-phase drug development, and they can accelerate the availability of new therapies in Asia.

On May 1, 2023, the U.S. Food and Drug Administration (FDA) released an updated Draft Guidance on decentralized trials. This release shows that the landscape of clinical research is rapidly evolving. The shift towards decentralized clinical trials presents an exciting opportunity for sponsors to improve patient engagement, enhance data quality, and accelerate clinical research. Are you prepared for what’s to come? Download the insight brief to learn more.

Key challenges and strategies to consider when developing devices intended for home-use or deployment in a clinical research setting.